The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Dihydroartemisinin-Global Market Insights and Sales Trends 2025
Synopsis
The global Dihydroartemisinin market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Dihydroartemisinin in various end use industries. The expanding demands from the Malaria Treatment, Scientific Research and Others,, are propelling Dihydroartemisinin market. Pharmaceutical Grade, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Industrial Grade segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Dihydroartemisinin market, driven by demand from China, the second largest economy with some signs of stabilising, the Dihydroartemisinin market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Dihydroartemisinin, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Dihydroartemisinin market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Dihydroartemisinin market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Dihydroartemisinin sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Dihydroartemisinin covered in this report include Sanofi, KPC Pharmaceuticals, Guangxi Xiancaotang Pharmaceutical, Guilin Pharmaceutical, Kerui Nanhai Pharmaceutical, Shanghai Natural Bio-engineering Co, Novanat Bioresource and Botanical Extracts EPZ Ltd, etc.
The global Dihydroartemisinin market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Sanofi
KPC Pharmaceuticals
Guangxi Xiancaotang Pharmaceutical
Guilin Pharmaceutical
Kerui Nanhai Pharmaceutical
Shanghai Natural Bio-engineering Co
Novanat Bioresource
Botanical Extracts EPZ Ltd
Global Dihydroartemisinin market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Dihydroartemisinin market, Segment by Type:
Pharmaceutical Grade
Industrial Grade
Global Dihydroartemisinin market, by Application
Malaria Treatment
Scientific Research
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Dihydroartemisinin manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Dihydroartemisinin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
The global Dihydroartemisinin market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Dihydroartemisinin in various end use industries. The expanding demands from the Malaria Treatment, Scientific Research and Others,, are propelling Dihydroartemisinin market. Pharmaceutical Grade, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Industrial Grade segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Dihydroartemisinin market, driven by demand from China, the second largest economy with some signs of stabilising, the Dihydroartemisinin market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Dihydroartemisinin, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Dihydroartemisinin market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Dihydroartemisinin market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Dihydroartemisinin sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Dihydroartemisinin covered in this report include Sanofi, KPC Pharmaceuticals, Guangxi Xiancaotang Pharmaceutical, Guilin Pharmaceutical, Kerui Nanhai Pharmaceutical, Shanghai Natural Bio-engineering Co, Novanat Bioresource and Botanical Extracts EPZ Ltd, etc.
The global Dihydroartemisinin market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Sanofi
KPC Pharmaceuticals
Guangxi Xiancaotang Pharmaceutical
Guilin Pharmaceutical
Kerui Nanhai Pharmaceutical
Shanghai Natural Bio-engineering Co
Novanat Bioresource
Botanical Extracts EPZ Ltd
Global Dihydroartemisinin market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Dihydroartemisinin market, Segment by Type:
Pharmaceutical Grade
Industrial Grade
Global Dihydroartemisinin market, by Application
Malaria Treatment
Scientific Research
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Dihydroartemisinin manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Dihydroartemisinin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Dihydroartemisinin Market Overview
1.1 Dihydroartemisinin Product Overview
1.2 Dihydroartemisinin Market Segment by Type
1.2.1 Pharmaceutical Grade
1.2.2 Industrial Grade
1.3 Global Dihydroartemisinin Market Size by Type
1.3.1 Global Dihydroartemisinin Market Size Overview by Type (2018-2029)
1.3.2 Global Dihydroartemisinin Historic Market Size Review by Type (2018-2023)
1.3.3 Global Dihydroartemisinin Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Dihydroartemisinin Sales Breakdown by Type (2018-2023)
1.4.2 Europe Dihydroartemisinin Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Dihydroartemisinin Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Dihydroartemisinin Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Dihydroartemisinin Sales Breakdown by Type (2018-2023)
2 Global Dihydroartemisinin Market Competition by Company
2.1 Global Top Players by Dihydroartemisinin Sales (2018-2023)
2.2 Global Top Players by Dihydroartemisinin Revenue (2018-2023)
2.3 Global Top Players by Dihydroartemisinin Price (2018-2023)
2.4 Global Top Manufacturers Dihydroartemisinin Manufacturing Base Distribution, Sales Area, Product Type
2.5 Dihydroartemisinin Market Competitive Situation and Trends
2.5.1 Dihydroartemisinin Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Dihydroartemisinin Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Dihydroartemisinin as of 2022)
2.7 Date of Key Manufacturers Enter into Dihydroartemisinin Market
2.8 Key Manufacturers Dihydroartemisinin Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Dihydroartemisinin Status and Outlook by Region
3.1 Global Dihydroartemisinin Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Dihydroartemisinin Historic Market Size by Region
3.2.1 Global Dihydroartemisinin Sales in Volume by Region (2018-2023)
3.2.2 Global Dihydroartemisinin Sales in Value by Region (2018-2023)
3.2.3 Global Dihydroartemisinin Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Dihydroartemisinin Forecasted Market Size by Region
3.3.1 Global Dihydroartemisinin Sales in Volume by Region (2024-2029)
3.3.2 Global Dihydroartemisinin Sales in Value by Region (2024-2029)
3.3.3 Global Dihydroartemisinin Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Dihydroartemisinin by Application
4.1 Dihydroartemisinin Market Segment by Application
4.1.1 Malaria Treatment
4.1.2 Scientific Research
4.1.3 Others
4.2 Global Dihydroartemisinin Market Size by Application
4.2.1 Global Dihydroartemisinin Market Size Overview by Application (2018-2029)
4.2.2 Global Dihydroartemisinin Historic Market Size Review by Application (2018-2023)
4.2.3 Global Dihydroartemisinin Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Dihydroartemisinin Sales Breakdown by Application (2018-2023)
4.3.2 Europe Dihydroartemisinin Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Dihydroartemisinin Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Dihydroartemisinin Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Dihydroartemisinin Sales Breakdown by Application (2018-2023)
5 North America Dihydroartemisinin by Country
5.1 North America Dihydroartemisinin Historic Market Size by Country
5.1.1 North America Dihydroartemisinin Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Dihydroartemisinin Sales in Volume by Country (2018-2023)
5.1.3 North America Dihydroartemisinin Sales in Value by Country (2018-2023)
5.2 North America Dihydroartemisinin Forecasted Market Size by Country
5.2.1 North America Dihydroartemisinin Sales in Volume by Country (2024-2029)
5.2.2 North America Dihydroartemisinin Sales in Value by Country (2024-2029)
6 Europe Dihydroartemisinin by Country
6.1 Europe Dihydroartemisinin Historic Market Size by Country
6.1.1 Europe Dihydroartemisinin Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Dihydroartemisinin Sales in Volume by Country (2018-2023)
6.1.3 Europe Dihydroartemisinin Sales in Value by Country (2018-2023)
6.2 Europe Dihydroartemisinin Forecasted Market Size by Country
6.2.1 Europe Dihydroartemisinin Sales in Volume by Country (2024-2029)
6.2.2 Europe Dihydroartemisinin Sales in Value by Country (2024-2029)
7 Asia-Pacific Dihydroartemisinin by Region
7.1 Asia-Pacific Dihydroartemisinin Historic Market Size by Region
7.1.1 Asia-Pacific Dihydroartemisinin Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Dihydroartemisinin Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Dihydroartemisinin Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Dihydroartemisinin Forecasted Market Size by Region
7.2.1 Asia-Pacific Dihydroartemisinin Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Dihydroartemisinin Sales in Value by Region (2024-2029)
8 Latin America Dihydroartemisinin by Country
8.1 Latin America Dihydroartemisinin Historic Market Size by Country
8.1.1 Latin America Dihydroartemisinin Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Dihydroartemisinin Sales in Volume by Country (2018-2023)
8.1.3 Latin America Dihydroartemisinin Sales in Value by Country (2018-2023)
8.2 Latin America Dihydroartemisinin Forecasted Market Size by Country
8.2.1 Latin America Dihydroartemisinin Sales in Volume by Country (2024-2029)
8.2.2 Latin America Dihydroartemisinin Sales in Value by Country (2024-2029)
9 Middle East and Africa Dihydroartemisinin by Country
9.1 Middle East and Africa Dihydroartemisinin Historic Market Size by Country
9.1.1 Middle East and Africa Dihydroartemisinin Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Dihydroartemisinin Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Dihydroartemisinin Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Dihydroartemisinin Forecasted Market Size by Country
9.2.1 Middle East and Africa Dihydroartemisinin Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Dihydroartemisinin Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Sanofi
10.1.1 Sanofi Company Information
10.1.2 Sanofi Introduction and Business Overview
10.1.3 Sanofi Dihydroartemisinin Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Sanofi Dihydroartemisinin Products Offered
10.1.5 Sanofi Recent Development
10.2 KPC Pharmaceuticals
10.2.1 KPC Pharmaceuticals Company Information
10.2.2 KPC Pharmaceuticals Introduction and Business Overview
10.2.3 KPC Pharmaceuticals Dihydroartemisinin Sales, Revenue and Gross Margin (2018-2023)
10.2.4 KPC Pharmaceuticals Dihydroartemisinin Products Offered
10.2.5 KPC Pharmaceuticals Recent Development
10.3 Guangxi Xiancaotang Pharmaceutical
10.3.1 Guangxi Xiancaotang Pharmaceutical Company Information
10.3.2 Guangxi Xiancaotang Pharmaceutical Introduction and Business Overview
10.3.3 Guangxi Xiancaotang Pharmaceutical Dihydroartemisinin Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Guangxi Xiancaotang Pharmaceutical Dihydroartemisinin Products Offered
10.3.5 Guangxi Xiancaotang Pharmaceutical Recent Development
10.4 Guilin Pharmaceutical
10.4.1 Guilin Pharmaceutical Company Information
10.4.2 Guilin Pharmaceutical Introduction and Business Overview
10.4.3 Guilin Pharmaceutical Dihydroartemisinin Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Guilin Pharmaceutical Dihydroartemisinin Products Offered
10.4.5 Guilin Pharmaceutical Recent Development
10.5 Kerui Nanhai Pharmaceutical
10.5.1 Kerui Nanhai Pharmaceutical Company Information
10.5.2 Kerui Nanhai Pharmaceutical Introduction and Business Overview
10.5.3 Kerui Nanhai Pharmaceutical Dihydroartemisinin Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Kerui Nanhai Pharmaceutical Dihydroartemisinin Products Offered
10.5.5 Kerui Nanhai Pharmaceutical Recent Development
10.6 Shanghai Natural Bio-engineering Co
10.6.1 Shanghai Natural Bio-engineering Co Company Information
10.6.2 Shanghai Natural Bio-engineering Co Introduction and Business Overview
10.6.3 Shanghai Natural Bio-engineering Co Dihydroartemisinin Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Shanghai Natural Bio-engineering Co Dihydroartemisinin Products Offered
10.6.5 Shanghai Natural Bio-engineering Co Recent Development
10.7 Novanat Bioresource
10.7.1 Novanat Bioresource Company Information
10.7.2 Novanat Bioresource Introduction and Business Overview
10.7.3 Novanat Bioresource Dihydroartemisinin Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Novanat Bioresource Dihydroartemisinin Products Offered
10.7.5 Novanat Bioresource Recent Development
10.8 Botanical Extracts EPZ Ltd
10.8.1 Botanical Extracts EPZ Ltd Company Information
10.8.2 Botanical Extracts EPZ Ltd Introduction and Business Overview
10.8.3 Botanical Extracts EPZ Ltd Dihydroartemisinin Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Botanical Extracts EPZ Ltd Dihydroartemisinin Products Offered
10.8.5 Botanical Extracts EPZ Ltd Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Dihydroartemisinin Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Dihydroartemisinin Industrial Chain Analysis
11.4 Dihydroartemisinin Market Dynamics
11.4.1 Dihydroartemisinin Industry Trends
11.4.2 Dihydroartemisinin Market Drivers
11.4.3 Dihydroartemisinin Market Challenges
11.4.4 Dihydroartemisinin Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Dihydroartemisinin Distributors
12.3 Dihydroartemisinin Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Chemicals Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
